FUNCTIONAL BRANDS INC (MEHA)
NASDAQHealth CarePackaged FoodsSnapshot 2026-09-04
$0.00-0.30%
Close 2026-09-04 · 1-day change
NASDAQHealth CarePackaged FoodsSnapshot 2026-09-04
QuarterlyIQ Insights · MEHA
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on improving financial stability by managing costs and strengthening the balance sheet amid ongoing operating losses and cash usage.
Newly stated in 2026-Q2. Management emphasized strengthening the balance sheet and managing costs amid a widening operating loss from $0.16 million in 2025-Q2 to $1.3 million in 2026-Q2 and a cash decline from $2.7 million at end 2025 to $352,142 at 2026-Q2. The financials show increasing losses and cash usage, indicating the company is facing significant financial challenges and is focused on cost and balance sheet management.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated weak grew net income 28% of the time over the next year (vs 52% for the rest of the cohort, n=10029).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Our focus now is on strengthening our balance sheet, managing our cost structure, and executing on the core nutraceutical business.”
Continue to pursue mergers and acquisitions, including asset purchases, to expand the company's portfolio and capabilities.
Stated in 2 of last 2 quarters. Management pursued acquisition of BullionFX assets in 2026-Q1 and 2026-Q2 but the agreement was terminated in 2026-Q2. This indicates active pursuit of M&A but with a recent setback, showing ongoing effort but limited delivery on this priority so far.
“Entered into Asset Purchase Agreement with BullionFX to acquire blockchain assets, later terminated.”
“Entered into Material Definitive Agreement for acquisition of BullionFX assets.”
Management communicated rationale targeting activation of new initiatives in the third quarter of 2026.
Newly stated in 2026-Q2. Management has set a target to activate new initiatives in Q3 2026. No financial results yet available for Q3 2026 to assess delivery, so trajectory is pending.
“Management communicates rationale targeting activation in Q3 2026.”
Focus on managing financial performance given ongoing operating losses and negative net income.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, long-term interest rates, the US dollar, real (inflation-adjusted) rates, Fed net liquidity (low R² over the window).
19 material management or governance events in the past 24 months, led by M&A activity. Historically, Health Care names rated volatile grew net income 53% of the time over the next year (vs 50% for the rest of the cohort, n=3986).
Not investment advice. As of 2026-09-04.